|Articles|September 17, 2019

PE 2020 Media Kit

External Link - PE_2020_MediaKit_final_r1.pdf

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe

Related Content

What Life Sciences CEOs Are Losing Sleep Over in 2026

ByKen Banta

September 11th 2026

Pharmaceutical Executive Daily: Novartis Shareholders Raise Concerns over M&A Strategy

ByNicholas Jacobus

September 11th 2026

Leveraging Synthetic Advisory Boards for Sharper Biopharma Decisions

ByNacho Quinones, Ph.D.,Aisling O'Loughlin, Ph.D.

September 11th 2026

Novartis Investors Share Concerns Over M&A Strategy: Report

ByNicholas Jacobus

September 11th 2026

The Orchestra Needs a Conductor: Why Health Care Doesn’t Need More Point Solutions

ByMichelle Carnahan

September 11th 2026

PE 2020 Media Kit

Related Content

What Life Sciences CEOs Are Losing Sleep Over in 2026

Pharmaceutical Executive Daily: Novartis Shareholders Raise Concerns over M&A Strategy

Leveraging Synthetic Advisory Boards for Sharper Biopharma Decisions

Novartis Investors Share Concerns Over M&A Strategy: Report

The Orchestra Needs a Conductor: Why Health Care Doesn’t Need More Point Solutions

Trending on PharmExec

The Agentic AI Revolution in Biopharma

How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications

Novartis Investors Share Concerns Over M&A Strategy: Report

Artisan Partners’ Director Calls for Novartis Board Shake-Up

Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum